These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 30941974)

  • 1. Effects of diabetes mellitus and Metformin administration on prostate cancer detection at biopsy among Chinese men: a case-control study.
    Hu MB; Bai PD; Wu YS; Zhang LM; Zhu WH; Hu JM; Yang T; Jiang HW; Ding Q
    J BUON; 2019; 24(1):227-232. PubMed ID: 30941974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between metformin use and risk of prostate cancer and its grade.
    Margel D; Urbach D; Lipscombe LL; Bell CM; Kulkarni G; Austin PC; Fleshner N
    J Natl Cancer Inst; 2013 Aug; 105(15):1123-31. PubMed ID: 23853056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of metformin use on the risk of prostate cancer after prostate biopsy in patients with high grade intraepithelial neoplasia.
    Dell'Atti L; Galosi AB
    Int Braz J Urol; 2018; 44(1):69-74. PubMed ID: 29211393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The risk of prostate cancer for men on aspirin, statin or antidiabetic medications.
    Nordström T; Clements M; Karlsson R; Adolfsson J; Grönberg H
    Eur J Cancer; 2015 Apr; 51(6):725-33. PubMed ID: 25727881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin use and risk of prostate cancer: results from the REDUCE study.
    Feng T; Sun X; Howard LE; Vidal AC; Gaines AR; Moreira DM; Castro-Santamaria R; Andriole GL; Freedland SJ
    Cancer Prev Res (Phila); 2015 Nov; 8(11):1055-60. PubMed ID: 26353947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidiabetic drug use and prostate cancer risk in the Finnish Randomized Study of Screening for Prostate Cancer.
    Haring A; Murtola TJ; Talala K; Taari K; Tammela TL; Auvinen A
    Scand J Urol; 2017 Feb; 51(1):5-12. PubMed ID: 28084175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin Does Not Predict for Prostate Cancer Diagnosis, Grade, or Volume of Disease After Transperineal Template-guided Mapping Biopsy.
    Merrick GS; Bennett A; Couture T; Butler WM; Galbreath RW; Adamovich E
    Am J Clin Oncol; 2017 Aug; 40(4):353-357. PubMed ID: 25575041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of diabetes mellitus on the detection of prostate cancer via contemporary multi (≥ 12)-core prostate biopsy.
    Hong SK; Oh JJ; Byun SS; Hwang SI; Lee HJ; Choe G; Lee SE
    Prostate; 2012 Jan; 72(1):51-7. PubMed ID: 21520162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of diabetes mellitus on high-grade prostate cancer detection among Japanese obese patients with prostate-specific antigen less than 10 ng/mL.
    Fukushima H; Masuda H; Kawakami S; Ito M; Sakura M; Numao N; Koga F; Saito K; Fujii Y; Yamamoto S; Yonese J; Fukui I; Kihara K
    Urology; 2012 Jun; 79(6):1329-34. PubMed ID: 22656412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin effects on biochemical recurrence and metabolic signaling in the prostate.
    Winters B; Plymate S; Zeliadt SB; Holt S; Zhang X; Hu E; Lin DW; Morrissey C; Wooldridge B; Gore JL; Porter MP; Wright JL
    Prostate; 2015 Nov; 75(15):1694-703. PubMed ID: 26201966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate cancer diagnosis among men with isolated high-grade intraepithelial neoplasia enrolled onto a 3-year prospective phase III clinical trial of oral toremifene.
    Taneja SS; Morton R; Barnette G; Sieber P; Hancock ML; Steiner M
    J Clin Oncol; 2013 Feb; 31(5):523-9. PubMed ID: 23295793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin use and prostate cancer risk.
    Preston MA; Riis AH; Ehrenstein V; Breau RH; Batista JL; Olumi AF; Mucci LA; Adami HO; Sørensen HT
    Eur Urol; 2014 Dec; 66(6):1012-20. PubMed ID: 24857538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin and the incidence of prostate cancer in patients with type 2 diabetes.
    Azoulay L; Dell'Aniello S; Gagnon B; Pollak M; Suissa S
    Cancer Epidemiol Biomarkers Prev; 2011 Feb; 20(2):337-44. PubMed ID: 21148757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissecting the association between metabolic syndrome and prostate cancer risk: analysis of a large clinical cohort.
    Bhindi B; Locke J; Alibhai SMH; Kulkarni GS; Margel DS; Hamilton RJ; Finelli A; Trachtenberg J; Zlotta AR; Toi A; Hersey KM; Evans A; van der Kwast TH; Fleshner NE
    Eur Urol; 2015 Jan; 67(1):64-70. PubMed ID: 24568896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk Assessment.
    Tomlins SA; Day JR; Lonigro RJ; Hovelson DH; Siddiqui J; Kunju LP; Dunn RL; Meyer S; Hodge P; Groskopf J; Wei JT; Chinnaiyan AM
    Eur Urol; 2016 Jul; 70(1):45-53. PubMed ID: 25985884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The utility of PSA velocity in prediction of prostate cancer and high grade cancer after an initially negative prostate biopsy.
    Elshafei A; Li YH; Hatem A; Moussa AS; Ethan V; Krishnan N; Li J; Jones JS
    Prostate; 2013 Dec; 73(16):1796-802. PubMed ID: 24038200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship Between Prebiopsy Multiparametric Magnetic Resonance Imaging (MRI), Biopsy Indication, and MRI-ultrasound Fusion-targeted Prostate Biopsy Outcomes.
    Meng X; Rosenkrantz AB; Mendhiratta N; Fenstermaker M; Huang R; Wysock JS; Bjurlin MA; Marshall S; Deng FM; Zhou M; Melamed J; Huang WC; Lepor H; Taneja SS
    Eur Urol; 2016 Mar; 69(3):512-7. PubMed ID: 26112001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Significance of Proliferative Inflammatory Atrophy in Negative Prostatic Biopsies.
    Servian P; Celma A; Planas J; Placer J; de Torres IM; Morote J
    Prostate; 2016 Dec; 76(16):1501-1506. PubMed ID: 27404228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between metformin medication, genetic variation and prostate cancer risk.
    Lee MJ; Jayalath VH; Xu W; Lu L; Freedland SJ; Fleshner NE; Kulkarni GS; Finelli A; van der Kwast TH; Hamilton RJ
    Prostate Cancer Prostatic Dis; 2021 Mar; 24(1):96-105. PubMed ID: 32424261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of diabetes mellitus with prostate cancer grade and prostate-specific antigen in Chinese biopsy population.
    Chen M; Luo Y; Yang S; Xu L; Li N; Li H; Qu S
    Diabetes Res Clin Pract; 2018 Jul; 141():80-87. PubMed ID: 29684617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.